Related Experiment Videos
Prevention of closure of aorto-coronary venous bypass grafts
Insights
This study investigated preventing aorto-coronary saphenous vein bypass graft closure. Acetylsalicylic acid and anticoagulants were compared to no antithrombotic drugs, assessing graft potency after 18-24 months.
Area of Science:
- Cardiovascular Surgery
- Vascular Surgery
- Interventional Cardiology
Background:
- Aorto-coronary saphenous vein bypass grafts significantly relieve angina and improve patient capacity.
- Graft occlusion due to thrombosis occurs in ~10% postoperatively and 2-3% annually.
- Angina recurrence is linked to graft closure or coronary artery disease progression.
Purpose of the Study:
- To evaluate the efficacy of antithrombotic therapy in preventing aorto-coronary saphenous vein bypass graft closure.
- To assess the impact of acetylsalicylic acid and anticoagulants on graft patency.
- To determine the long-term effect of preventing graft occlusion on patient outcomes.
Main Methods:
- A randomized clinical study involving 142 patients undergoing bypass surgery.
- Intervention group (72 patients) received acetylsalicylic acid (1 gm daily) and anticoagulants post-operation.
- Control group (70 patients) received no antithrombotic drugs and were advised to avoid anti-inflammatory agents.
- Follow-up at 18-24 months included re-catheterization and selective angiography to assess graft potency.
Main Results:
- The study aims to assess the effect of therapy on graft potency as the primary outcome measure.
- Long-term graft patency rates will be compared between the treatment and control groups.
- The impact of antithrombotic therapy on preventing graft occlusion will be determined.
Conclusions:
- The study will provide crucial data on the effectiveness of antithrombotic strategies in maintaining bypass graft patency.
- Findings will inform clinical practice regarding the management of patients following aorto-coronary bypass surgery.
- This research seeks to reduce angina recurrence and improve long-term outcomes by preventing graft closure.
Abstract:
Aorto-coronary saphenous vein bypass graft implantation has led to a considerable relief of angina in a great majority of patients. Their functional capacity has been increased, and life possibly prolonged. During the postoperative period approximately ten per cent of the grafts occlude because of thrombosis, and later 2-3 per cent occlude per year. The angina returns in some patients, which is related either to graft closure or to progression of arteriosclerotic disease in the coronary arteries. A randomized clinical study has therefore been started in 142 patients in order to prevent graft closure. Two to three days after operation, one group of 72 receive acetylsalicylic acid, one gm. daily, and anticoagulants, while the 70 patients in the control group receive no antithrombotic drugs, and are asked to avoid anti-inflammatory agents. After 18 to 24 months, they are admitted for follow-up, including re-catheterization with selective angiography of coronary arteries or grafts. The effect of therapy will be assessed from graft potency alone.